Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial fibrillation in the elderly

M Reardon1, A J Camm

  • 1Department of Geriatrics, St. George's Hospital, London, U.K.

Clinical Cardiology
|October 1, 1996
PubMed
Summary

Atrial fibrillation (AF) is common in older adults, increasing stroke risk and mortality. Treatment involves rhythm control, rate control, and anticoagulation, with decisions guided by risk-benefit assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse effects of amiodarone at low dose: plus ça change.

Journal of the American College of Cardiology·1997
Same author

Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system.

Pacing and clinical electrophysiology : PACE·1997
Same author

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.

Japanese circulation journal·1997
Same author

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Circulation·1997
Same author

Chlamydia pneumoniae and coronary heart disease.

BMJ (Clinical research ed.)·1997
Same author

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.

Lancet (London, England)·1997

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • Atrial fibrillation (AF) prevalence increases significantly with age, affecting 11% of those over 70 and 17% of those 84+.
  • AF is linked to substantial one-year mortality (0.2-16%), particularly in the elderly.
  • Patients with AF face a 4.8-fold higher risk of stroke.

Purpose of the Study:

  • To summarize the epidemiology, risks, and management strategies for atrial fibrillation in the elderly population.

Main Methods:

  • Literature review of epidemiological data and clinical guidelines for atrial fibrillation management.
  • Analysis of risk factors, mortality rates, and stroke risk associated with AF.
  • Overview of current therapeutic options including cardioversion, rate control, and anticoagulation.

Main Results:

  • High prevalence and mortality rates of AF in elderly individuals.
  • Significant association between AF and increased stroke risk.
  • Established treatment modalities for AF include electrical/pharmacological cardioversion, rate-controlling drugs, and anticoagulation.

Conclusions:

  • Atrial fibrillation poses a considerable health burden in the elderly, marked by high mortality and stroke risk.
  • Management requires a tailored approach, balancing the benefits of anticoagulation against bleeding risks.
  • Effective management strategies include rhythm and rate control alongside careful consideration of anticoagulation therapy.

Related Experiment Videos